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INTRODUCTION: The increasing frequency of use of CT in patientswith acute abdomen is likely to improve
the diagnosis of rarely occurring conditions/causes such as superior mesenteric vein thrombosis (MVT).
Despite its severe consequences, MVT often presents with nonspeciﬁc clinical features.
PRESENTATION OF CASE: AD, a 64-year-old man was an emergency admission with vague abdominal
discomfort of two weeks duration, acute upper abdominal pain, loose stools, fresh rectal bleeding and
vomiting. A contrast enhanced abdominal CT showed thrombosis of the proximal portal vein and the
entire length of the superior mesenteric vein (SMV) with small bowel ischaemia extending from the
terminal ileum to the mid jejunal loops. Tests for paroxysmal nocturnal haemoglobinuria and Janus
kinase 2 mutation yielded negative results. AD was readmitted seven months later with small bowel
obstruction requiring segmental small bowel resection with end-to-end anastomosis. Abdominal CT had
shown complete resolution of MVT but a small bowel stricture.
DISCUSSION: Thrombosis limited to mesenteric veins results in earlier and more frequent development
of infarction compared to portal combined with mesenteric venous thrombosis. Most patients may be
successfully treatedwith anti-coagulation therapy alone. However, surgerymay be required to deal with
intestinal infarction or late sequela of MVT.
CONCLUSION: This case demonstrates that MVT can be reversed by effective anticoagulation. However,
the price paid for a mild to moderate effect on the bowel may be signiﬁcant stricture later on. Patients
escaping early bowel resection due tomassiveMVT leading to bowel infarctionmay still require resection
later due to stricture.
© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-SA license (http://creativecommons.org/licenses/by-nc-sa/3.0/).
1. Introduction
Acute mesenteric venous thrombosis (MVT) is an uncommon
but established cause of intestinal ischaemia, distinct frommesen-
teric arterial occlusion. Diagnosis of early MVT is difﬁcult due to
lack of characteristic laboratory abnormalities or distinct physi-
cal features prior to the development of gut ischemia or autopsy.1
Early identiﬁcation of the condition allows for conservative treat-
ment with anticoagulation and improved outcomes.2 This has led
to a change in the approach to the initial management with non-
operative therapy being preferred to surgery. However, bowel
stricture may develop in rare cases due to ischaemia, and a close
follow-up of every patient after treatment for mesenteric vein
thrombosis is necessary to ensure early diagnosis of this compli-
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cation. We report a case of extensive thrombosis of the proximal
portal vein and entire superiormesenteric vein successfully treated
conservatively, but whom seven months later developed small
bowel obstruction due to stricture.
2. Case report
AD, a 64-year-oldmanwas an emergency admissionwith vague
abdominal discomfort of two weeks duration, acute upper abdom-
inal pain, loose stools, fresh rectal bleeding and vomiting. His past
medical history included pulmonary embolism 14 months previ-
ously for which he had been under anticoagulation therapy with
warfarin for six months and hypertension treated with lisinopril
and amlodipine. He previously smoked a pipe (one ounce per day)
for 12 years and stopped eight years prior to admission. He had no
history of obesity.
On admission he exhibited tenderness in the mid-abdominal
and right upper quadrant regions. Routine laboratory evaluation
revealed leucocytosis [count of 12.7×109/L, with predominant
http://dx.doi.org/10.1016/j.ijscr.2014.11.071
2210-2612/© 2014 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-SA license
(http://creativecommons.org/licenses/by-nc-sa/3.0/).
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Fig. 1. Contrast enhancedabdominal CT showing superiormesenteric veinoccluded
by thrombosis (red arrow).
neutrophilia (neutrophils 11.4)], a raised C-reactive protein (CRP)
of 111 (normal: 0.1–5mg/L) and normal liver function tests. On
suspicion of biliary pathology, an abdominal Ultrasound was per-
formed, which revealed signiﬁcant free ﬂuid within the abdomen
and a long segment of thickened small bowel thought to be due
to inﬂammatory bowel disease. A contrast enhanced abdominal
computed tomography (CT) showed extensive thrombosis of the
proximal portal vein and the entire length of the superior mesen-
teric vein (SMV) with small bowel ischaemia extending from the
terminal ileum to the mid jejunal loops (Fig. 1). An incidental ﬁnd-
ing of a 6mm well deﬁned, peripherally based nodule in the right
lower pulmonary lobe was noted but this was discounted when
a follow-up thorax CT performed three months later without any
progression.
AD was started on anticoagulation with high dose of enoxa-
parin (low molecular weight heparin) 150mg daily in addition to
IV antibiotics (co-trimoxazole and metronidazole). Furthermore,
he was commenced on IV ﬂuids; a nasogastric tube was inserted
to relieve bowel obstruction, and parenteral nutrition via a cen-
tral venous catheter. AD responded to these conservativemeasures
and resumed normal bowel movement. The ﬂuorescently labelled
inactive toxin aerolysin (FLAER) test for paroxysmal nocturnal
haemoglobinuria (PNH) and DNA PCR V617F detection of Janus
Kinase 2 (JAK2) mutation yielded negative results. Anticoagula-
tion was changed to warfarin, aiming on an INR of 2.5, and he was
discharged home 12 days after admission. AD was seen in the out-
patient clinic at three and six months and ﬁnally discharged for
care.
AD was readmitted as an emergency with a one day cramp-
ing abdominal pain, distention and biliary vomiting seven months
after his initial presentation. Examination revealed abdominal dis-
tention with palpable bowel loops, diffuse abdominal tenderness
and normal digital rectal examination. Routine laboratory evalu-
ation revealed leucocytosis (11.8×109/L) and a CRP of 10mg/L.
CT imaging of the abdomen revealed features of mechanical small
bowel obstruction (Fig. 2), most probably due to a post ischaemic
small bowel stricture. The previously noted thrombus in the SMV
had resolved. The symptoms resolvedwith conservative treatment,
but he was electively re-admitted one week later for segmental
resection of 30 cm of small bowel with end-to-end anastomosis.
He did well and was discharged home ﬁve days later. Histological
Fig. 2. Transition between dilated small bowel (yellow arrow) and strictured bowel
(red arrow).
evaluation of the specimen revealed ulceration and active chronic
inﬂammationwith perforation (histopathological ﬁnding only) and
surrounding granulation tissue formation without any evidence of
neoplasia.
3. Discussion
MVT is a rare condition accounting for between1 in15,000 and1
in5000 admissions tohospital and6–9%of all cases of acutemesen-
teric ischemia.3,4 The prevalence of MVT has increased over the
past two decades with the increased use of contrast-enhanced CT
in patients presenting with abdominal pain and those with por-
tal hypertension. CT is generally the imaging modality of choice
due to its high sensitivity (90–100%), wide availability and rela-
tively low cost. Ultrasound with Doppler analysis of ﬂow in the
mesenteric and portal venous systems has also been usedwith suc-
cess, albeit with a lower sensitivity (73–80%) and higher level of
technical difﬁculty.1
Different pathophysiologic mechanisms have been postulated
for acute thrombus formation, local factors, such as recent
splenectomy or pancreatitis associated with initial thrombosis
in the large veins; and systemic hypercoagulable factors such
as protein C deﬁciency or myeloproliferative disease that lead
to thrombosis beginning in the intramural venules, vasa recta
and venous arcades.5 The main causes of MVT are abdominal
malignant neoplasm, surgery, inﬂammatory conditions, inher-
ited disorders (protein C or S deﬁciency, factor V Leiden
deﬁciency, antithrombin deﬁciency), or acquired (hematologic dis-
eases: polycythaemiavera,myeloﬁbrosis, thrombocythaemia, JAK2
gene sequence variation, antiphosholipid antibodies, paroxysmal
nocturnal haemoglobinuria; non hematologic diseases: malig-
nancy, oral contraceptive pills, pregnancy, nephrotic syndrome,
hyperhomocysteinaemia).6–8 Detection of the JAK2 sequence vari-
ation has replaced bone marrow examination as the ﬁrst test for
screening myeloproliferative diseases because it can differenti-
ate reactive thrombocytosis from essential thrombocythaemia and
primary from secondary polycythaemia.9 With the use of more
extensive investigation, the frequency of patients with primary
MVT has decreased, varying from 0% to 49% in the literature.10
Investigations did not yield any underlying aetiology in our case
and it can therefore be assumed he had idiopathic or primaryMVT.
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MVT impairs venous return from the bowel, resulting in venous
engorgement and ischemia. With rapid and complete occlusion of
mesenteric veins, theremaybe insufﬁcient time fordevelopmentof
a collateral circulation leading to transmural bowel infarction. The
transition fromnormal to ischemic bowel is gradual, unlike in arte-
rial ischemia when it is more abrupt. Arterial spasm secondary to
venous engorgement may occur, with resulting irreversible bowel
ischemia, despite treatment of venous thrombosis. Associated por-
tal venous thrombosis as in this case can be seen if the disease
originates in the major veins instead of the small vena rectae.
Thrombosis limited to mesenteric veins results in earlier andmore
frequent development of infarction compared to portal combined
with mesenteric venous thrombosis. This is thought to be due to
the fact that withMVT, usually the thrombotic process starts in the
small veinswithin the bowelwall thereby not allowing time for gut
drainage via the collateral system.11 With transmural infarction,
there is loss of integrity of the bowel mucosa, allowing bacterial
translocation and potential for occurrence of lactic acidosis, sepsis,
multiorgan failure and death.6
The management of MVT includes preventing further exten-
sion of the thrombus and intestinal infraction in the short term;
and avoiding the sequela of mild gut ischaemia and recurrence of
thrombosis. Anticoagulation is the main stay of management.2–4
It is not only beneﬁcial in recanalising thrombosed veins12, but
reduces themeandurationof hospital stay, hospitalmortality, need
for surgery and the risk of short bowel syndrome.2 This should
be combined with other ancillary measures, such as pain control,
replacement of ﬂuids, including blood transfusionwhen needed for
gastrointestinal bleeding, nasogastric aspiration, broad-spectrum
antibiotics.13 Prophylactic antibiotics are usually required to deal
with potential sepsis due to bacterial translocation through the
oedematous bowelwall as a result of venous congestion. Bowel rest
and total parenteral nutrition support is beneﬁcial as absorption
from the intestine is initially impaired.
When intestinal infarction is suspected, immediate exploration
of the abdomen is advised. Bowel viability at surgery is determined
by visual inspection, Doppler ultrasonography, or ﬂuorescein infu-
sion, with the latter being the most accurate mean for detecting
bowel viability.13,14 Resection and anastomosis is the standard pro-
cedure, with the goal of conserving as much bowel as possible.1 A
planned “second-look” operation during the ﬁrst 24–48 postop-
erative hours, to reassess any intestinal segments of questionable
viability may limit the extent of the initial resection.3 For obvi-
ous reasons, resection for a late occurring stricture has better
prognosis than for early spreading bowel infarction.10 Direct and
indirect portal vein and superior mesenteric vein thrombolysis
have been used in patientswith high risk for bowel obstruction, but
without obvious intestinal necrosis, perforation and peritonitis.15
Jun K.W. et al. reported two patients with portal and supe-
rior mesenteric vein thrombosis who were successfully treated
by percutaneous transhepatic mechanical thrombectomy-assisted
thrombolysis. They however, noted that because MVT is a rare
disease, there was insufﬁcient evidence regarding the efﬁcacy of
mechanical thrombectomy.16
Stenosis of the small bowel is rarely mentioned in reports of
MVT suggesting it may be a rare complication.17,18 Themechanism
is probably due to mild to moderate ischaemia not severe enough
to cause immediate infarction. In our patient, the bowel occlu-
sion developed during the post-thrombotic course, and resulted
in surgical resection. As the patient improved promptly with con-
servative management, it was adjudged better to perform his
operation electively on the next available list. The diagnosis of
intestinal stricture in patients with a history of MVT should prob-
ably be considered more often and earlier in the presence of
abdominal symptoms. This would lead to more prompt treatment
and better outcome.
4. Conclusion
This case demonstrates that MVT can be reversed by effective
anticoagulation. However, the price paid for a mild to moderate
effect on the bowel may be signiﬁcant stricture later on. Patients
escaping early bowel resection due to massive MVT leading to
bowel infarction may still require resection later due to stricture.
Patients need to be counselled along these lines.
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